ERIN BUTLER: Open Payments
NPI 1194141127 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,547 in 110 payments from 44 companies in 2025. Trend: 2023 $164 · 2024 $1,148 · 2025 $2,547
Food & beverage: $2,547
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $215 |
| Novartis Pharmaceuticals Corporation | 10 | $182 |
| Ipsen Biopharmaceuticals, Inc | 3 | $156 |
| Janssen Biotech, Inc. | 8 | $151 |
| Merck Sharp & Dohme LLC | 6 | $134 |
| Celgene Corporation | 6 | $133 |
| Daiichi Sankyo Inc. | 5 | $120 |
| AstraZeneca Pharmaceuticals LP | 4 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $105 |
| ABBVIE INC. | 5 | $102 |
Products named: Onivyde, LIBTAYO, REBLOZYL, EPKINLY, KISQALI, KEYTRUDA, ENHERTU, Venclexta.
Industry payments across KY — which companies pay providers there.
